n-((1h-Imidazol-2-yl)methyl)propan-2-amine, 98%, 250mg

Ethyl Benzoate>99.0%(GC)25mL

(2-(Trifluoromethyl)pyridin-4-yl)boronic acid, 95.0%, 1g

Recipiente de cristalización DURAN® sin pico, 3500 ml, 230 mm, 1 Pieza

[(3r)-6-fluoro-1,2,3,4-tetrahydroisoquinolin-3-yl]methanol, 98%, 250mg

Sodium 5-isopropyl-3,8-dimethylazulene-1-sulfonate, 95.0%, 25g

Valnemulin Hydrochloride>98.0%(HPLC)250mg

N,N'-BIS[3-(2-METHOXYPHENYL)-2-HYDROXYBENZYL](1R,2R)-1,2-CYCLOHEXANEDIAMINE, 95%, 100mg

N-benzyl-4-piperidinecarboxamide hydrochloride, 95.0%, 1g

(S)-METHYL 4,4-DIMETHYLPYRROLIDINE-2-CARBOXYLATE HCL, 95%, 250mg

Propyl Methanesulfonate>98.0%(GC)25g

Sal de p-toluidina fosfato de 5-bromo-4-cloro-3-indolilo, 1 g

(R)-1-m-Tolylethanamine, 95.0%, 5g